Welcome to Regeneus

Regeneus Ltd (ASX: RGS) is an Australian clinical-stage regenerative medicine company developing a portfolio of innovative cellular therapies targeting significant unmet medical needs in both human and animal health markets.

Our initial focus is on osteoarthritis (OA), cancer, inflammatory skin conditions and wound healing.
The Company’s product pipeline is underpinned by proprietary stem cell and immuno-oncology technologies.

Therapeutic areas



Skin conditions & wound healing

Latest news